DarioHealth
DRIO
5 hedge funds and large institutions have $20K invested in DarioHealth in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Emerson Investment Management
Boston,
Massachusetts
|
+$46.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.19K |
| 3 |
AIG
American International Group
New York
|
+$3.1K |
| 4 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
+$3.1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.55K |
Top Sellers
DRIO Hedge Fund Activity: Q1 2016 in Review
5 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2016, worth a combined $20K.
Buyers outnumbered sellers: 5 funds opened new DRIO positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Emerson Investment Management, opening a new position worth an estimated $46.4K.
- 5 institutional investors held DarioHealth (DRIO) as of Q1 2016, up from 0 in Q4 2015.
- Funds reported $20K of DarioHealth stock for Q1 2016.
- 5 funds opened new DarioHealth positions in Q1 2016 and 0 closed out, a net change of +5 holders.
- The largest DarioHealth buyer in Q1 2016 was Emerson Investment Management, an estimated $46.4K added.
Based on aggregated 13F filings for Q1 2016.